Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.
Levicept develops biological agent for the treatment of chronic pain.
Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults.
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.
Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
MiroBio is Harnessing the natural control mechanisms of the immune system.
Aldena Therapeutics is a private biotech startup that invented siRNA-based treatments for dermatological conditions.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
Alys Pharmaceuticals is a biopharmaceutical company focused on developing immuno-dermatology treatments.
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Ethyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.
Janpix operates as an oncology-focused startup.
Alderaan is a biotechnology company.
Medicxi has invested in 43 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Medicxi's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 13 different industry categories.
Among tracked funding rounds, Vaxcyte received $632.5M in a Post Ipo Equity round. Medicxi's total known invested capital is $2.2B.
Medicxi's average investment size is $61.4M across its portfolio of 43 companies.
Recent Medicxi portfolio additions include Vicebio, Levicept, Versanis Bio, Vaderis Therapeutics, Sydnexis. These companies were founded in 2020 or later.